Yan Du
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- MicroRNA in disease regulation 2
-
- Immune cells in cancer 4
- Galectins and Cancer Biology 3
- Journals
- Journal of Oncology (2 papers)Cancer Research (1 paper)Journal of Personalized Medicine (1 paper)Infection and Drug Resistance (1 paper)Aging (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yan Du
19 papers receiving 865 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 309
- Oncology 233
- Immunology 141
- Biomedical Engineering 258
- Molecular Biology 351
Countries citing papers authored by Yan Du
This map shows the geographic impact of Yan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Du more than expected).
Fields of papers citing papers by Yan Du
This network shows the impact of papers produced by Yan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Du. The network helps show where Yan Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions Hit paper breakdown → | 2023 | 761 |
| 10 | 2022 | 4 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 12 | |
| 17 | 2020 | 8 | |
| 18 | 2019 | 11 | |
| 19 | 2018 | 5 | |
| 20 | 2018 | 0 |
About Yan Du
Yan Du is a scholar working on Cancer Research, Immunology, Oncology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 873 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (5 papers), Immune cells in cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Galectins and Cancer Biology (3 papers), Epigenetics and DNA Methylation (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (309 citations), Oncology (233 citations), Immunology (141 citations), Biomedical Engineering (258 citations) and Molecular Biology (351 citations). Yan Du has collaborated with scholars based in China and United States. Frequent co-authors include Wence Zhou, Zhou Chen, Huaqing Shi, Fangfang Han, Jie Yao, Peng Xu, Wenkai Jiang, Wenlong Zhang, Zhennan Li and Jianjun Qian. Their work appears in journals such as Journal of Oncology, Cancer Research, Journal of Personalized Medicine, Infection and Drug Resistance and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.